source name	characteristics[biological replicate]	characteristics[organism]	characteristics[organism part]	characteristics[ancestry category]	characteristics[cell type]	characteristics[age]	characteristics[sex]	characteristics[disease]	characteristics[individual]	characteristics[enrichment process]	characteristics[chemical entity]	assay name	technology type	comment[cleavage agent details]	comment[cleavage agent details]	comment[cleavage agent details]	comment[fractionation method]	comment[fractionation identifier]	comment[fragment mass tolerance]	comment[instrument]	comment[label]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[precursor mass tolerance]	comment[technical replicate]	comment[tool metadata]	comment[data file]	factor value[disease]	factor value[chemical entity]
omentum normal crude	1	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 1	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	not applicable	not applicable	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150324_121_AN_G42_C1_2h.raw	normal	not applicable
omentum HGSOC crude	1	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 2	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	not applicable	not applicable	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150330_121_AN_G138_C2_2h.raw	metastatic ovarian high grade serous adenocarcinoma	not applicable
omentum HGSOC urea-soluble	1	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 3	proteomic profiling by mass spectrometry	not applicable	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	not applicable	not applicable	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150330_121_AN_G138_S2_2h.raw	metastatic ovarian high grade serous adenocarcinoma	NT=supernatant;AC=SIO:010425
omentum normal urea-soluble	1	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 4	proteomic profiling by mass spectrometry	not applicable	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	not applicable	not applicable	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150330_121_AN_G42_S1_2h.raw	normal	NT=supernatant;AC=SIO:010425
omentum HGSOC crude	1	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 5	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	1	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150603_121_AN_G138_C2_f1.raw	metastatic ovarian high grade serous adenocarcinoma	not applicable
omentum HGSOC crude	1	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 6	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	10	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150603_121_AN_G138_C2_f10.raw	metastatic ovarian high grade serous adenocarcinoma	not applicable
omentum HGSOC crude	1	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 7	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	11	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150603_121_AN_G138_C2_f11.raw	metastatic ovarian high grade serous adenocarcinoma	not applicable
omentum HGSOC crude	1	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 8	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	12	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150603_121_AN_G138_C2_f12.raw	metastatic ovarian high grade serous adenocarcinoma	not applicable
omentum HGSOC crude	1	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 9	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	13	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150603_121_AN_G138_C2_f13.raw	metastatic ovarian high grade serous adenocarcinoma	not applicable
omentum HGSOC crude	1	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 10	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	14	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150603_121_AN_G138_C2_f14.raw	metastatic ovarian high grade serous adenocarcinoma	not applicable
omentum HGSOC crude	1	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 11	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	15	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150603_121_AN_G138_C2_f15.raw	metastatic ovarian high grade serous adenocarcinoma	not applicable
omentum HGSOC crude	1	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 12	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	2	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150603_121_AN_G138_C2_f2_b.raw	metastatic ovarian high grade serous adenocarcinoma	not applicable
omentum HGSOC crude	1	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 13	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	3	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150603_121_AN_G138_C2_f3.raw	metastatic ovarian high grade serous adenocarcinoma	not applicable
omentum HGSOC crude	1	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 14	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	4	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150603_121_AN_G138_C2_f4.raw	metastatic ovarian high grade serous adenocarcinoma	not applicable
omentum HGSOC crude	1	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 15	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	5	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150603_121_AN_G138_C2_f5.raw	metastatic ovarian high grade serous adenocarcinoma	not applicable
omentum HGSOC crude	1	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 16	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	6	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150603_121_AN_G138_C2_f6.raw	metastatic ovarian high grade serous adenocarcinoma	not applicable
omentum HGSOC crude	2	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 17	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	7	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150603_121_AN_G138_C2_f7.raw	metastatic ovarian high grade serous adenocarcinoma	not applicable
omentum HGSOC crude	2	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 18	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	8	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150603_121_AN_G138_C2_f8.raw	metastatic ovarian high grade serous adenocarcinoma	not applicable
omentum HGSOC crude	2	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 19	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	9	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150603_121_AN_G138_C2_f9.raw	metastatic ovarian high grade serous adenocarcinoma	not applicable
omentum HGSOC urea-soluble	2	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 20	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	1	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150603_121_AN_G138_S2_f1.raw	metastatic ovarian high grade serous adenocarcinoma	NT=supernatant;AC=SIO:010425
omentum HGSOC urea-soluble	2	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 21	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	10	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150603_121_AN_G138_S2_f10.raw	metastatic ovarian high grade serous adenocarcinoma	NT=supernatant;AC=SIO:010425
omentum HGSOC urea-soluble	2	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 22	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	11	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150603_121_AN_G138_S2_f11.raw	metastatic ovarian high grade serous adenocarcinoma	NT=supernatant;AC=SIO:010425
omentum HGSOC urea-soluble	2	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 23	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	12	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150603_121_AN_G138_S2_f12.raw	metastatic ovarian high grade serous adenocarcinoma	NT=supernatant;AC=SIO:010425
omentum HGSOC urea-soluble	2	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 24	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	13	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150603_121_AN_G138_S2_f13.raw	metastatic ovarian high grade serous adenocarcinoma	NT=supernatant;AC=SIO:010425
omentum HGSOC urea-soluble	2	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 25	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	14	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150603_121_AN_G138_S2_f14.raw	metastatic ovarian high grade serous adenocarcinoma	NT=supernatant;AC=SIO:010425
omentum HGSOC urea-soluble	2	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 26	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	15	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150603_121_AN_G138_S2_f15.raw	metastatic ovarian high grade serous adenocarcinoma	NT=supernatant;AC=SIO:010425
omentum HGSOC urea-soluble	2	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 27	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	2	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150603_121_AN_G138_S2_f2.raw	metastatic ovarian high grade serous adenocarcinoma	NT=supernatant;AC=SIO:010425
omentum HGSOC urea-soluble	2	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 28	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	3	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150603_121_AN_G138_S2_f3.raw	metastatic ovarian high grade serous adenocarcinoma	NT=supernatant;AC=SIO:010425
omentum HGSOC urea-soluble	2	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 29	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	4	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150603_121_AN_G138_S2_f4.raw	metastatic ovarian high grade serous adenocarcinoma	NT=supernatant;AC=SIO:010425
omentum HGSOC urea-soluble	2	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 30	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	5	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150603_121_AN_G138_S2_f5.raw	metastatic ovarian high grade serous adenocarcinoma	NT=supernatant;AC=SIO:010425
omentum HGSOC urea-soluble	2	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 31	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	6	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150603_121_AN_G138_S2_f6.raw	metastatic ovarian high grade serous adenocarcinoma	NT=supernatant;AC=SIO:010425
omentum HGSOC urea-soluble	2	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 32	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	7	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150603_121_AN_G138_S2_f7.raw	metastatic ovarian high grade serous adenocarcinoma	NT=supernatant;AC=SIO:010425
omentum HGSOC urea-soluble	2	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 33	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	8	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150603_121_AN_G138_S2_f8.raw	metastatic ovarian high grade serous adenocarcinoma	NT=supernatant;AC=SIO:010425
omentum HGSOC urea-soluble	1	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 34	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	9	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150603_121_AN_G138_S2_f9.raw	metastatic ovarian high grade serous adenocarcinoma	NT=supernatant;AC=SIO:010425
omentum normal crude	1	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 35	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	1	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150911_174_AN_G138_C1_f1.raw	normal	not applicable
omentum normal crude	1	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 36	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	10	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150911_174_AN_G138_C1_f10.raw	normal	not applicable
omentum normal crude	1	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 37	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	11	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150911_174_AN_G138_C1_f11.raw	normal	not applicable
omentum normal crude	1	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 38	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	12	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150911_174_AN_G138_C1_f12.raw	normal	not applicable
omentum normal crude	1	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 39	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	13	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150911_174_AN_G138_C1_f13.raw	normal	not applicable
omentum normal crude	1	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 40	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	14	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150911_174_AN_G138_C1_f14.raw	normal	not applicable
omentum normal crude	1	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 41	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	15	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150911_174_AN_G138_C1_f15.raw	normal	not applicable
omentum normal crude	1	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 42	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	2	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150911_174_AN_G138_C1_f2.raw	normal	not applicable
omentum normal crude	1	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 43	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	3	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150911_174_AN_G138_C1_f3.raw	normal	not applicable
omentum normal crude	1	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 44	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	4	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150911_174_AN_G138_C1_f4.raw	normal	not applicable
omentum normal crude	1	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 45	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	5	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150911_174_AN_G138_C1_f5.raw	normal	not applicable
omentum normal crude	1	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 46	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	6	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150911_174_AN_G138_C1_f6.raw	normal	not applicable
omentum normal crude	1	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 47	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	7	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150911_174_AN_G138_C1_f7.raw	normal	not applicable
omentum normal crude	1	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 48	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	8	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150911_174_AN_G138_C1_f8.raw	normal	not applicable
omentum normal crude	1	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 49	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	9	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150911_174_AN_G138_C1_f9.raw	normal	not applicable
omentum normal urea-soluble	2	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 50	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	1	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150911_174_AN_G138_S1_f1.raw	normal	NT=supernatant;AC=SIO:010425
omentum normal urea-soluble	2	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 51	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	10	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150911_174_AN_G138_S1_f10.raw	normal	NT=supernatant;AC=SIO:010425
omentum normal urea-soluble	2	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 52	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	11	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150911_174_AN_G138_S1_f11.raw	normal	NT=supernatant;AC=SIO:010425
omentum normal urea-soluble	2	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 53	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	12	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150911_174_AN_G138_S1_f12.raw	normal	NT=supernatant;AC=SIO:010425
omentum normal urea-soluble	2	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 54	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	13	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150911_174_AN_G138_S1_f13.raw	normal	NT=supernatant;AC=SIO:010425
omentum normal urea-soluble	2	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 55	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	14	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150911_174_AN_G138_S1_f14.raw	normal	NT=supernatant;AC=SIO:010425
omentum normal urea-soluble	2	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 56	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	15	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150911_174_AN_G138_S1_f15.raw	normal	NT=supernatant;AC=SIO:010425
omentum normal urea-soluble	2	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 57	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	2	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150911_174_AN_G138_S1_f2.raw	normal	NT=supernatant;AC=SIO:010425
omentum normal urea-soluble	2	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 58	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	3	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150911_174_AN_G138_S1_f3.raw	normal	NT=supernatant;AC=SIO:010425
omentum normal urea-soluble	2	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 59	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	4	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150911_174_AN_G138_S1_f4.raw	normal	NT=supernatant;AC=SIO:010425
omentum normal urea-soluble	2	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 60	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	5	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150911_174_AN_G138_S1_f5.raw	normal	NT=supernatant;AC=SIO:010425
omentum normal urea-soluble	2	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 61	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	6	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150911_174_AN_G138_S1_f6.raw	normal	NT=supernatant;AC=SIO:010425
omentum normal urea-soluble	2	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 62	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	7	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150911_174_AN_G138_S1_f7.raw	normal	NT=supernatant;AC=SIO:010425
omentum normal urea-soluble	2	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 63	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	8	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150911_174_AN_G138_S1_f8.raw	normal	NT=supernatant;AC=SIO:010425
omentum normal urea-soluble	2	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 64	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	9	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	150911_174_AN_G138_S1_f9.raw	normal	NT=supernatant;AC=SIO:010425
omentum HGSOC crude	2	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 65	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	not applicable 	not applicable	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160123_210_AN_10.raw	metastatic ovarian high grade serous adenocarcinoma	not applicable
TNBC-adjacent crude	1	homo sapiens	breast	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 66	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	not applicable	not applicable	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160123_210_AN_12.raw	normal	not applicable
TNBC pellet 1	1	homo sapiens	breast	not available	not available	not available	F	triple-negative breast cancer	not available	NT= Extraction purification; AC=NCIT:C113061	NT=centrifugation pellet; AC=SIO:010424	run 67	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	not applicable	not applicable	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160123_210_AN_13.raw	triple-negative breast cancer	NT=centrifugation pellet; AC=SIO:010424
TNBC pellet 2	1	homo sapiens	breast	not available	not available	not available	F	triple-negative breast cancer	not available	NT= Extraction purification; AC=NCIT:C113061	NT=centrifugation pellet; AC=SIO:010424	run 68	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	not applicable	not applicable	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160123_210_AN_14.raw	triple-negative breast cancer	NT=centrifugation pellet; AC=SIO:010424
TNBC-adjacent pellet	1	homo sapiens	breast	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	NT=centrifugation pellet; AC=SIO:010424	run 69	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	not applicable	not applicable	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160123_210_AN_15.raw	normal	NT=centrifugation pellet; AC=SIO:010424
omentum HGSOC pellet	1	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	NT=centrifugation pellet; AC=SIO:010424	run 70	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	not applicable	not applicable	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160123_210_AN_16.raw	metastatic ovarian high grade serous adenocarcinoma	NT=centrifugation pellet; AC=SIO:010424
omentum normal pellet	1	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	NT=centrifugation pellet; AC=SIO:010424	run 71	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	not applicable	not  applicable	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160123_210_AN_17.raw	normal	NT=centrifugation pellet; AC=SIO:010424
TNBC-adjacent pellet p2	1	homo sapiens	breast	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	NT=centrifugation pellet; AC=SIO:010424	run 72	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	not applicable	not applicable	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160123_210_AN_18.raw	normal	NT=centrifugation pellet; AC=SIO:010424
TNBC urea-soluble p1	1	homo sapiens	breast	not available	not available	not available	F	triple-negative breast cancer	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 73	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	not applicable	not applicable	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160123_210_AN_2.raw	triple-negative breast cancer	NT=supernatant;AC=SIO:010425
TNBC-adjacent urea-soluble	1	homo sapiens	breast	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 74	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	not applicable	not applicable	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160123_210_AN_3.raw	normal	NT=supernatant;AC=SIO:010425
omentum normal urea-soluble	1	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 75	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	not applicable	not applicable	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160123_210_AN_5.raw	normal	NT=supernatant;AC=SIO:010425
TNBC crude p2	1	homo sapiens	breast	not available	not available	not available	F	triple-negative breast cancer	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 76	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	not applicable	not applicable	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160123_210_AN_7.raw	triple-negative breast cancer	not applicable
TNBC crude p1	1	homo sapiens	breast	not available	not available	not available	F	triple-negative breast cancer	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 77	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	not applicable	not applicable	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160123_210_AN_8.raw	triple-negative breast cancer	not applicable
TNBC urea-soluble p2	1	homo sapiens	breast	not available	not available	not available	F	triple-negative breast cancer	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 78	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	not applicable	not applicable	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160129_210_AN_1.raw	triple-negative breast cancer	NT=supernatant;AC=SIO:010425
TNBC-adjacent urea-soluble p2	1	homo sapiens	breast	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 79	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	not applicable	not applicable	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160129_210_AN_6.raw	normal	NT=supernatant;AC=SIO:010425
TNBC-adjacent crude p1	1	homo sapiens	breast	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 80	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	not applicable	not applicable	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160129_210_AN_9.raw	normal	not applicable
omentum normal crude	1	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 81	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	not applicable	not applicable 	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160218_210_AN_11.raw	normal	not applicable
omentum HGSOC urea-soluble 	2	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 82	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	not applicable 	not applicable	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160218_210_AN_4.raw	metastatic ovarian high grade serous adenocarcinoma	NT=supernatant;AC=SIO:010425
omentum HGSOC urea-soluble 	2	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 83	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	1	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160310_210_AN_4_f1.raw	metastatic ovarian high grade serous adenocarcinoma	NT=supernatant;AC=SIO:010425
omentum HGSOC urea-soluble 	2	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 84	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	10	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160310_210_AN_4_f10.raw	metastatic ovarian high grade serous adenocarcinoma	NT=supernatant;AC=SIO:010425
omentum HGSOC urea-soluble 	2	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 85	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	11	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160310_210_AN_4_f11.raw	metastatic ovarian high grade serous adenocarcinoma	NT=supernatant;AC=SIO:010425
omentum HGSOC urea-soluble 	2	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 86	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	12	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160310_210_AN_4_f12.raw	metastatic ovarian high grade serous adenocarcinoma	NT=supernatant;AC=SIO:010425
omentum HGSOC urea-soluble 	2	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 87	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	13	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160310_210_AN_4_f13.raw	metastatic ovarian high grade serous adenocarcinoma	NT=supernatant;AC=SIO:010425
omentum HGSOC urea-soluble 	2	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 88	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	14	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160310_210_AN_4_f14.raw	metastatic ovarian high grade serous adenocarcinoma	NT=supernatant;AC=SIO:010425
omentum HGSOC urea-soluble 	2	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 89	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	15	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160310_210_AN_4_f15.raw	metastatic ovarian high grade serous adenocarcinoma	NT=supernatant;AC=SIO:010425
omentum HGSOC urea-soluble 	2	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 90	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	2	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160310_210_AN_4_f2.raw	metastatic ovarian high grade serous adenocarcinoma	NT=supernatant;AC=SIO:010425
omentum HGSOC urea-soluble 	2	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 91	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	3	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160310_210_AN_4_f3.raw	metastatic ovarian high grade serous adenocarcinoma	NT=supernatant;AC=SIO:010425
omentum HGSOC urea-soluble 	2	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 92	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	4	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160310_210_AN_4_f4.raw	metastatic ovarian high grade serous adenocarcinoma	NT=supernatant;AC=SIO:010425
omentum HGSOC urea-soluble 	2	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 93	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	5	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160310_210_AN_4_f5.raw	metastatic ovarian high grade serous adenocarcinoma	NT=supernatant;AC=SIO:010425
omentum HGSOC urea-soluble 	2	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 94	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	6	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160310_210_AN_4_f6.raw	metastatic ovarian high grade serous adenocarcinoma	NT=supernatant;AC=SIO:010425
omentum HGSOC urea-soluble 	2	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 95	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	7	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160310_210_AN_4_f7.raw	metastatic ovarian high grade serous adenocarcinoma	NT=supernatant;AC=SIO:010425
omentum HGSOC urea-soluble 	2	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 96	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	8	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160310_210_AN_4_f8.raw	metastatic ovarian high grade serous adenocarcinoma	NT=supernatant;AC=SIO:010425
omentum HGSOC urea-soluble 	2	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 97	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	9	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160310_210_AN_4_f9.raw	metastatic ovarian high grade serous adenocarcinoma	NT=supernatant;AC=SIO:010425
omentum HGSOC crude 	2	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 98	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	1	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160315_210_AN_10_f1.raw	metastatic ovarian high grade serous adenocarcinoma	not applicable
omentum HGSOC crude 	1	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 99	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	10	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160315_210_AN_10_f10.raw	metastatic ovarian high grade serous adenocarcinoma	not applicable
omentum HGSOC crude 	1	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 100	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	11	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160315_210_AN_10_f11.raw	metastatic ovarian high grade serous adenocarcinoma	not applicable
omentum HGSOC crude 	1	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 101	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	12	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160315_210_AN_10_f12.raw	metastatic ovarian high grade serous adenocarcinoma	not applicable
omentum HGSOC crude 	1	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 102	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	13	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160315_210_AN_10_f13.raw	metastatic ovarian high grade serous adenocarcinoma	not applicable
omentum HGSOC crude 	1	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 103	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	14	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160315_210_AN_10_f14.raw	metastatic ovarian high grade serous adenocarcinoma	not applicable
omentum HGSOC crude 	1	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 104	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	15	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160315_210_AN_10_f15.raw	metastatic ovarian high grade serous adenocarcinoma	not applicable
omentum HGSOC crude 	1	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 105	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	2	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160315_210_AN_10_f2.raw	metastatic ovarian high grade serous adenocarcinoma	not applicable
omentum HGSOC crude 	1	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 106	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	3	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160315_210_AN_10_f3.raw	metastatic ovarian high grade serous adenocarcinoma	not applicable
omentum HGSOC crude 	1	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 107	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	4	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160315_210_AN_10_f4.raw	metastatic ovarian high grade serous adenocarcinoma	not applicable
omentum HGSOC crude 	1	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 108	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	5	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160315_210_AN_10_f5.raw	metastatic ovarian high grade serous adenocarcinoma	not applicable
omentum HGSOC crude 	1	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 109	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	6	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160315_210_AN_10_f6.raw	metastatic ovarian high grade serous adenocarcinoma	not applicable
omentum HGSOC crude 	1	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 110	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	7	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160315_210_AN_10_f7.raw	metastatic ovarian high grade serous adenocarcinoma	not applicable
omentum HGSOC crude 	1	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 111	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	8	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160315_210_AN_10_f8.raw	metastatic ovarian high grade serous adenocarcinoma	not applicable
omentum HGSOC crude 	1	homo sapiens	omentum	not available	not available	not available	F	metastatic ovarian high grade serous adenocarcinoma	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 112	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	9	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160315_210_AN_10_f9.raw	metastatic ovarian high grade serous adenocarcinoma	not applicable
omentum normal crude	1	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 113	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	1	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160317_210_AN_11_f1.raw	normal	not applicable
omentum normal crude	1	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 114	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	10	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160317_210_AN_11_f10.raw	normal	not applicable
omentum normal crude	2	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 115	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	11	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160317_210_AN_11_f11.raw	normal	not applicable
omentum normal crude	2	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 116	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	12	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160317_210_AN_11_f12.raw	normal	not applicable
omentum normal crude	2	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 117	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	13	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160317_210_AN_11_f13.raw	normal	not applicable
omentum normal crude	2	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 118	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	14	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160317_210_AN_11_f14.raw	normal	not applicable
omentum normal crude	2	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 119	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	15	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160317_210_AN_11_f15.raw	normal	not applicable
omentum normal crude	2	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 120	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	2	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160317_210_AN_11_f2.raw	normal	not applicable
omentum normal crude	2	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 121	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	3	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160317_210_AN_11_f3.raw	normal	not applicable
omentum normal crude	2	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 122	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	4	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160317_210_AN_11_f4.raw	normal	not applicable
omentum normal crude	2	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 123	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	5	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160317_210_AN_11_f5.raw	normal	not applicable
omentum normal crude	2	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 124	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	6	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160317_210_AN_11_f6.raw	normal	not applicable
omentum normal crude	2	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 125	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	7	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160317_210_AN_11_f7.raw	normal	not applicable
omentum normal crude	2	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 126	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	8	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160317_210_AN_11_f8.raw	normal	not applicable
omentum normal crude	2	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	not applicable	run 127	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	9	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160317_210_AN_11_f9.raw	normal	not applicable
omentum normal urea-soluble 	2	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 128	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	1	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160403_210_AN_5_f1.raw	normal	NT=supernatant;AC=SIO:010425
omentum normal urea-soluble 	2	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 129	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	10	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160403_210_AN_5_f10.raw	normal	NT=supernatant;AC=SIO:010425
omentum normal urea-soluble 	2	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 130	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	11	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160403_210_AN_5_f11.raw	normal	NT=supernatant;AC=SIO:010425
omentum normal urea-soluble 	1	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 131	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	12	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160403_210_AN_5_f12.raw	normal	NT=supernatant;AC=SIO:010425
omentum normal urea-soluble 	2	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 132	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	2	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160403_210_AN_5_f2.raw	normal	NT=supernatant;AC=SIO:010425
omentum normal urea-soluble 	2	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 133	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	3	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160403_210_AN_5_f3.raw	normal	NT=supernatant;AC=SIO:010425
omentum normal urea-soluble 	1	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 134	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	4	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160403_210_AN_5_f4.raw	normal	NT=supernatant;AC=SIO:010425
omentum normal urea-soluble 	1	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 135	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	5	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160403_210_AN_5_f5.raw	normal	NT=supernatant;AC=SIO:010425
omentum normal urea-soluble 	2	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 136	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	6	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160403_210_AN_5_f6.raw	normal	NT=supernatant;AC=SIO:010425
omentum normal urea-soluble 	2	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 137	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	7	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160403_210_AN_5_f7.raw	normal	NT=supernatant;AC=SIO:010425
omentum normal urea-soluble 	1	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 138	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	8	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160403_210_AN_5_f8.raw	normal	NT=supernatant;AC=SIO:010425
omentum normal urea-soluble 	1	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 139	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	9	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160403_210_AN_5_f9.raw	normal	NT=supernatant;AC=SIO:010425
omentum normal urea-soluble 	2	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 140	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	13	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160405_210_AN_5_f13.raw	normal	NT=supernatant;AC=SIO:010425
omentum normal urea-soluble 	1	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 141	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	14	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160405_210_AN_5_f14.raw	normal	NT=supernatant;AC=SIO:010425
omentum normal urea-soluble 	2	homo sapiens	omentum	not available	not available	not available	F	normal	not available	NT= Extraction purification; AC=NCIT:C113061	NT=supernatant;AC=SIO:010425	run 142	proteomic profiling by mass spectrometry	NT=Trypsin;AC=MS:1001251;CS=(?<=[KR])(?!P)	NT=Lys-C; AC=MS:1001309;CS='(?<=K)(?\!P)'	NT=N-glycosidase F; AC=CHMO:0002921	high-pH reversed-phase chromatography (hpHRP)	15	0.8 Da	NT=Q Exactive; AC=MS:1001911	label free sample	NT=Carbamidomethyl;AC=4;CF=H(3) C(2) N O;MM=57.021464;MT=Fixed;PP=Anywhere;TA=['C']	NT=Gln->pyro-Glu;AC=28;CF=H(-3) N(-1);MM=-17.026549;MT=Variable;PP=Protein N-term;TA=['Q']	NT=Deamidated;AC=7;CF=H(-1) N(-1) O;MM=0.984016;MT=Variable;PP=Anywhere;TA=['N']	NT=Oxidation;AC=35;CF=O;MM=15.994915;MT=Variable;PP=Anywhere;TA=['M']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['P']	NT=Hydroxylation;AC=MOP:0000673;MT=Variable;PP=Anywhere;TA=['K']	10 ppm	1	lesSDRF v0.1.0	160405_210_AN_5_f15.raw	normal	NT=supernatant;AC=SIO:010425